Table II.
Association between poor prognosis and CD147 in patients with hepatocellular carcinoma.
| Parameter | Univariate regression, OR (95% CI) | Multivariate regressiona, OR (95% CI) |
|---|---|---|
| Serum levels of CD147 (≥21.0 vs. <21.0 ng/ml) | 2.21 (1.09, 4.47) | 1.94 (0.96, 3.91) |
| Tissue expression of CD147 (positive vs. negative) | 2.11 (1.04, 4.27) | 3.13 (1.52, 6.43) |
a
Multivariate-adjusted ORs were matched for gender, age, ethnicity, serum levels of α-fetoprotein, onset of hepatitis B virus surface antigen, onset of cirrhosis, tumor size, number of tumors and tumor-nodes-metastasis stage. OR, odds ratio; CI, confidence interval.